Deaths and severe adverse events associated with anesthesia-assisted rapid opioid detoxification - New York City, 2012

Morbidity and Mortality Weekly Report

Volumn 62, Issue 38, 2013, Pages 777-780

  Berlin, David ^a   Farmer, Brenna M ^a   Rao, Rama B ^a   Rella, Joseph ^a   Kunins, Hillary ^b   Dowell, Deborah ^b   Graber, Nathan ^b   Hoffman, Robert S ^b   Karpati, Adam ^b   Weiss, Don ^b   Jones, Christopher ^c   Toprani, Amita ^d   Ridpath, Alison ^d  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANESTHESIA; CASE REPORT; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; NOTE; OPIATE ADDICTION; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; ANESTHESIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; OPIOID-RELATED DISORDERS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884914651     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. CDC. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR 2011;60:1487-92.
2. Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O'Brien S. Exposure to opioid maintenance treatment reduces long-term mortality. Addiction 2008;103:462-8.
3. Gowing L, Ali R, White JM. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev 2009;3:CD002025.
4. Amato L, Davoli M, Minozzi S, Ali R, Ferri M. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev 2013;2:CD003409.
5. Sees KL, Delucchi KL, Masson C, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA 2000;283:1303-10.
6. Friedmann PD, Lemon SC, Stein MD, D'Aunno TA. Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res 2003;38:887-903.
7. Gowing L, Ali R, White JM. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Cochrane Database Syst Rev 2010;1:CD002022.
8. Collins ED, Kleber HD, Whittington RA, Heitler NE. Anesthesia-assisted vs buprenorphine-or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. JAMA 2005;294:903-13.
9. American Society of Addiction Medicine. Public policy statement on rapid and ultra rapid opioid detoxification. 2005. Chevy Chase, MD: American Society of Addiction Medicine; 2005. Available at http://www.asam.org/docs/publicy-policy-statements/1rod-urod---rev-of-oadusa-4-051.pdf?sfvrsn=0.
10. Kienbaum P, Scherbaum N, Thürauf N, Michel MC, Gastpar M, Peters J. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns. Crit Care Med 2000;28:969-76.